BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11202378)

  • 1. Effect of eltenac in horses with induced endotoxaemia.
    MacKay RJ; Daniels CA; Bleyaert HF; Bailey JE; Gillis KD; Merritt AM; Katz TL; Johnson JC; Thompson KC
    Equine Vet J Suppl; 2000 Jun; (32):26-31. PubMed ID: 11202378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses.
    Baskett A; Barton MH; Norton N; Anders B; Moore JN
    Am J Vet Res; 1997 Nov; 58(11):1291-9. PubMed ID: 9361895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of multiple-dose administration of eltenac in horses.
    Dyke TM; Sams RA; Thompson KG; Ashcraft SM
    Am J Vet Res; 1998 Nov; 59(11):1447-50. PubMed ID: 9829405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of an effective dose of eltenac and its comparison with that of flunixin meglumine in horses after experimentally induced carpitis.
    Hamm D; Turchi P; Johnson JC; Lockwood PW; Thompson KC; Katz T
    Am J Vet Res; 1997 Mar; 58(3):298-302. PubMed ID: 9055978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin.
    Barton MH; Moore JN; Norton N
    Am J Vet Res; 1997 Nov; 58(11):1300-7. PubMed ID: 9361896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyxin B protects horses against induced endotoxaemia in vivo.
    Barton MH; Parviainen A; Norton N
    Equine Vet J; 2004 Jul; 36(5):397-401. PubMed ID: 15253079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a conjugate of polymyxin B-dextran 70 in horses with experimentally induced endotoxemia.
    MacKay RJ; Clark CK; Logdberg L; Lake P
    Am J Vet Res; 1999 Jan; 60(1):68-75. PubMed ID: 9918150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eltenac, a new anti-inflammatory and analgesic drug for horses: clinical aspects.
    Prügner W; Huber R; Lühmann R
    J Vet Pharmacol Ther; 1991 Jun; 14(2):193-9. PubMed ID: 1920607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hyperimmune equine plasma on clinical and cellular responses in a low-dose endotoxaemia model in horses.
    Forbes G; Church S; Savage CJ; Bailey SR
    Res Vet Sci; 2012 Feb; 92(1):40-4. PubMed ID: 21093001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane, prostaglandin I2 (epoprostenol), and the hemodynamic changes in equine endotoxin shock.
    Bottoms GD; Templeton CB; Fessler JF; Johnson MA; Roesel OF; Ewert KM; Adams SB
    Am J Vet Res; 1982 Jun; 43(6):999-1002. PubMed ID: 7049018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of early-phase endotoxin tolerance in horses.
    Allen GK; Campbell-Beggs C; Robinson JA; Johnson PJ; Green EM
    Equine Vet J; 1996 Jul; 28(4):269-74. PubMed ID: 8818592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS).
    Häfner D; Ibrahim M; Wollin L; Germann PG
    Exp Toxicol Pathol; 2003 Jul; 55(1):59-68. PubMed ID: 12940630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee. A double blind study comparing eltenac with oral diclofenac and placebo gel.
    Sandelin J; Harilainen A; Crone H; Hamberg P; Forsskåhl B; Tamelander G
    Scand J Rheumatol; 1997; 26(4):287-92. PubMed ID: 9310109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A toxicity study of eltenac, a nonsteroidal anti-inflammatory drug, in horses.
    Goodrich LR; Furr MO; Robertson JL; Warnick LD
    J Vet Pharmacol Ther; 1998 Feb; 21(1):24-33. PubMed ID: 9507454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hypertonic vs isotonic saline solution on responses to sublethal Escherichia coli endotoxemia in horses.
    Bertone JJ; Gossett KA; Shoemaker KE; Bertone AL; Schneiter HL
    Am J Vet Res; 1990 Jul; 51(7):999-1007. PubMed ID: 2202242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and urine nitric oxide concentrations in horses given below a low dose of endotoxin.
    Bueno AC; Seahorn TL; Cornick-Seahorn J; Horohov DW; Moore RM
    Am J Vet Res; 1999 Aug; 60(8):969-76. PubMed ID: 10451207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of platelet-activating factor antagonist L-691,880 on low-flow ischemia-reperfusion injury of the large colon in horses.
    Moore RM; Muir WW; Bertone AL; Oliver JL
    Vet Surg; 1998; 27(1):37-48. PubMed ID: 9449176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunomodulating effects of ketamine in horses with experimental endotoxemia.
    Alcott CJ; Sponseller BA; Wong DM; Davis JL; Soliman AM; Wang C; Hsu W
    J Vet Intern Med; 2011; 25(4):934-43. PubMed ID: 21745244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of dimethyl sulphoxide effects on initial response to endotoxin in the horse.
    Kelmer G; Doherty TJ; Elliott S; Saxton A; Fry MM; Andrews FM
    Equine Vet J; 2008 Jun; 40(4):358-63. PubMed ID: 18356128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid infusion of a phospholipid emulsion attenuates the effects of endotoxaemia in horses.
    Moore JN; Norton N; Barton MH; Hurley DJ; Reber AJ; Donovan DC; Vandenplas ML; Parker TS; Levine DM
    Equine Vet J; 2007 May; 39(3):243-8. PubMed ID: 17520976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.